Impulse control disorders in Parkinson's disease: a psychosocial perspective.

Journal of Clinical Psychology in Medical Settings
Mary DelaneyPaul Geoffrey Overton

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disease primarily characterised by motor symptoms. However, another feature of PD which is receiving increasing attention is the phenomenon of impulse control disorders (ICDs), such as pathological gambling. To date, research into ICDs in PD has centred on a biomedical model of cause, related to the effects of dopamine replacement therapy. However, there are several areas of discrepancy in the current biomedical account of ICDs in PD. In addition, we argue that social and psychological factors also need to be considered to achieve a more complete understanding of the phenomenon. We present a novel conceptual model which combines biomedical and psychosocial factors in the genesis of ICDs in PD and use the model to identify a number of potential treatment intervention points and to highlight important outstanding questions concerning the inter-relationship between psychosocial and biomedical factors in the genesis of ICDs in PD.

References

Oct 1, 1989·Clinical Neuropharmacology·R J UittiB Thiessen
Nov 1, 1989·Neurology·S E StarksteinR G Robinson
Feb 1, 1989·The British Journal of Clinical Psychology·B MacCarthy, R Brown
Apr 1, 1973·Journal of Chronic Diseases·E Singer
Mar 1, 1983·The British Journal of Psychiatry : the Journal of Mental Science·N P QuinnJ D Parkes
May 1, 1994·Psychological Bulletin·C G Greeno, R R Wing
Mar 1, 1993·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R C BlandG Stebelsky
Dec 22, 1998·Brain Research. Brain Research Reviews·K C Berridge, T E Robinson
May 17, 2000·Biological Psychiatry·E HollanderC Cartwright
Jul 14, 2000·Journal of the American Geriatrics Society·M F MendezD L Christine
Sep 29, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·J A MolinaF Bermejo
Oct 29, 2000·Trends in Neurosciences·J A ObesoC W Olanow
Nov 3, 2001·Science·C Holden
Jan 10, 2002·The Journal of Clinical Psychiatry·J E Grant, S W Kim
May 16, 2002·The Journal of Nervous and Mental Disease·Michel LejoyeuxJean Adès
Dec 14, 2002·Lancet·C E Clarke, M Guttman
Nov 26, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Anette SchragMarjan Jahanshahi
Mar 31, 2004·Journal of the Neurological Sciences·Karen MinzerHarvey S Singer
Apr 13, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Andrew H EvansAndrew J Lees
Apr 13, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Roger Kurlan
May 19, 2004·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Jon E Grant, Marc N Potenza
Aug 11, 2005·Scandinavian Journal of Immunology·K WingA Rudin
Jul 4, 2006·Biological Psychiatry·James I HudsonRonald C Kessler
Sep 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Claire ArdouinPaul Krack
Sep 15, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Hatice KumruEduardo Tolosa
Nov 11, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Robert H PietrzakNancy M Petry
Jan 19, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Andrew H Evans, Helmut Butzkueven
Feb 14, 2007·Archives of Neurology·Valerie VoonMateusz Zurowski
Jun 21, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·David A GallagherAnette Schrag
Jul 11, 2007·Current Opinion in Neurology·Valerie VoonTeri Thomsen
Jul 28, 2007·Disease-a-month : DM·Michael G MercuryAmy Kuechler
Aug 19, 2007·Annals of Neurology·Christophe BonvinPierre R Burkhard
Oct 2, 2007·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·Robert H PietrzakNancy M Petry
Oct 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Eugenia MamikonyanDaniel Weintraub
Nov 9, 2007·Parkinsonism & Related Disorders·Doron Merims, Nir Giladi
Nov 30, 2007·Nature Clinical Practice. Neurology·Marc N PotenzaDaniel Weintraub
Dec 11, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Ioannis U IsaiasAngelo Antonini
Mar 4, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·David DevosLuc Defebvre
Mar 12, 2008·The Neurologist·William Stamey, Joseph Jankovic
Aug 19, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Jaime KulisevskyUNKNOWN Trapecio Group Study

❮ Previous
Next ❯

Citations

Dec 10, 2013·Annual Review of Clinical Psychology·B B AverbeckA Djamshidian
Nov 21, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Samuel R ChamberlainJon E Grant
Mar 1, 2016·Expert Review of Neurotherapeutics·Adolfo Ramirez-ZamoraJosé Biller
Sep 26, 2015·Journal of Parkinson's Disease·Alonso Alvarado-BolañosCarlos Zuñiga-Ramírez
Jul 5, 2016·International Psychogeriatrics·Susan ZhangAdrian Carter
Jul 31, 2016·Psychology & Health·Jack K GarlovskyPaul G Overton
Nov 2, 2016·Journal of Parkinson's Disease·Gila BronnerTanya Gurevich
Jun 1, 2019·Expert Review of Neurotherapeutics·Carmine VitaleGabriella Santangelo
Sep 2, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marie Grall-BronnecGaëlle Challet-Bouju
Nov 17, 2016·Journal of Neural Transmission·Bernd LeplowGeorg Ebersbach
May 2, 2020·Journal of Neurology, Neurosurgery, and Psychiatry·Mark John KellyDavid Okai
Nov 12, 2020·Psychology and Psychotherapy·Nicolò ZarottiJane Simpson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.